ストックスクリーナーアプリを入手
22.61
3.17%
-0.74
アフターアワーズ：
22.58
-0.03
-0.13%
前日終値:
$23.35
開ける：
$23.16
24時間の取引高:
6.55M
Relative Volume:
0.93
時価総額：
$11.68B
収益：
$11.32B
当期純損益:
$-981.00M
株価収益率:
-11.58
EPS:
-1.9532
ネットキャッシュフロー:
$714.00M
1週間 パフォーマンス:
-0.04%
1か月 パフォーマンス:
+16.61%
6か月 パフォーマンス:
+12.43%
1年 パフォーマンス:
-18.93%
1日の値動き範囲:
$22.59
$23.71
1週間の範囲:
$21.16
$23.71
52週間の値動き範囲:
$15.73
$29.35
Baxter International Inc Stock (BAX) Company Profile
名前
Baxter International Inc
セクター
電話
(224) 948-2000
住所
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
22.61 | 12.06B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
345.42 | 142.49B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
158.17 | 44.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
70.26 | 34.44B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
39.79 | 34.76B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
198.99 | 29.41B | 5.54B | 1.52B | 1.74B | 10.37 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-31 | ダウングレード | Argus | Buy → Hold |
| 2025-08-04 | ダウングレード | Stifel | Buy → Hold |
| 2025-08-01 | ダウングレード | Goldman | Buy → Neutral |
| 2025-02-26 | 再開されました | Goldman | Buy |
| 2025-02-24 | アップグレード | Argus | Hold → Buy |
| 2025-02-20 | 再開されました | Barclays | Overweight |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-12-15 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-06-24 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Goldman | Neutral → Sell |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-18 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-18 | 繰り返されました | Raymond James | Outperform |
| 2022-02-18 | 繰り返されました | Stifel | Buy |
| 2022-02-18 | 繰り返されました | UBS | Neutral |
| 2022-02-18 | 繰り返されました | Wells Fargo | Overweight |
| 2022-02-11 | 開始されました | Goldman | Neutral |
| 2022-01-07 | 再開されました | Citigroup | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-09-03 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | ダウングレード | UBS | Buy → Neutral |
| 2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
| 2020-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2020-09-04 | ダウングレード | Argus | Buy → Hold |
| 2020-06-24 | 開始されました | Oppenheimer | Outperform |
| 2020-03-19 | アップグレード | Stifel | Hold → Buy |
| 2020-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-02 | アップグレード | Citigroup | Neutral → Buy |
| 2019-01-02 | アップグレード | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | アップグレード | Argus | Hold → Buy |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-05-17 | 再開されました | Piper Jaffray | Overweight |
| 2018-02-06 | 繰り返されました | Citigroup | Neutral |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
すべてを表示
Baxter International Inc (BAX) 最新ニュース
Baxter International Appoints Michael Lemberger as Director of People Analytics - hrtoday.in
Baxter International stock trades steadily as spin-off and portfolio reshaping reshape earnings prof - ad-hoc-news.de
Is Baxter International Inc (BAX) a Bargain After 3.2% Drop? GF Value Says Undervalued - GuruFocus
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter stock trades steady as spin-off and earnings reshape the profile - ad-hoc-news.de
Baxter International's Q2 2026 earnings: What to expect - MSN
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter stock holds steady as restructuring and spin-off reshape the portfolio - ad-hoc-news.de
Is Baxter’s Class I Respiratory Device Recall Reshaping the Investment Case for Baxter International (BAX)? - Sahm
Baxter International Updates Segment Reporting Structure and Metrics - The Globe and Mail
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - Stock Traders Daily
Baxter International (BAX) Announces Recast of Financial Reporti - GuruFocus
A Look at Baxter International Inc (BAX) After 3.4% Decline -- G - GuruFocus
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Baxter reorganizes to two segments, recasts prior-period segment results and discloses operational/organic sales metrics - TradingView
Baxter (NYSE: BAX) recasts 2025 segment sales and shows $505M loss - Stock Titan
Goldman Sachs Adjusts Price Target on Baxter International to $21 From $19, Maintains Neutral Rating - Moomoo
ETFs Investing in Baxter International Inc. Stocks - TradingView
Baxter stock reflects a diversified medical technology business - ad-hoc-news.de
Baxter International stock reflects a diversified medical portfolio and ongoing portfolio transforma - ad-hoc-news.de
Baxter International Inc. (BAX) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors - Business Wire
Retia Medical Adds Former Baxter Executive Christopher Benassi to Advisory Board - citybiz
Baxter International Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh - TradingView
Citi Sticks to Its Sell Rating for Baxter International (BAX) - The Globe and Mail
Baxter Beats Stable Value Fund 401(k) Plan Suit, For Good - Law360
A Look at Baxter International Inc (BAX) After 3.9% Decline -- G - GuruFocus
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Baxter International balances portfolio focus and steady operations - Ad Hoc News
Baxter International focuses on core medical technologies as investors watch US healthcare demand - ad-hoc-news.de
Baxter International Again Defeats 401(k) Stable Value Fund Suit - Bloomberg Law News
Baxter International (BAX) Is Up 7.2% After Dual Russell 2500 Index AdditionsWhat's Changed - simplywall.st
Baxter International's Q2 2026 Earnings: What to Expect - inkl
The Sigma Spectrum Infusion SystemBaxter International targets smarter IV safety - ad-hoc-news.de
Baxter International focuses on core healthcare business as investors watch its portfolio moves - ad-hoc-news.de
Why Baxter International Inc (BAX) May Struggle to Outperform: A Look at Future Challenges - GuruFocus
Is Baxter International (BAX) Fully Valued On Its Russell 2500 Index Additions? - Yahoo Finance
Will Dual Russell 2500 Inclusion and Stronger Sentiment Change Baxter International's (BAX) Narrative? - Yahoo Finance
Baxter International balances medical technology breadth with long-term investment themes - ad-hoc-news.de
Why Is Baxter (NYSE:BAX) Featured Across Major US Indices? - Kalkine Media
Baxter International focuses on core portfolio as investors weigh long-term growth prospects - ad-hoc-news.de
Evercore ISI Adjusts Price Target on Baxter International to $24 From $22 - Moomoo
Baxter International focuses on medical products as investors watch long-term strategy - ad-hoc-news.de
The Spectrum IQ Infusion System from Baxter Internationalsmart pumps push safer drug delivery - AD HOC NEWS
Baxter International focuses on medical products and patient care - AD HOC NEWS
The PrisMax SystemBaxter International extends care for chronic kidney patients - AD HOC NEWS
Baxter International Inc. Actuals & Estimates (SWB:BTL) - TradingView
Baxter International outlines its healthcare strategy as investors watch the stock - AD HOC NEWS
BAX News | BAXTER INTERNATIONAL INC (NYSE:BAX) - ChartMill
Baxter International Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Baxter International stock on the company backdrop. Trading stays tied to the wider health care setu - AD HOC NEWS
Baxter International Inc (BAX) 財務データ
収益
当期純利益
現金流量
EPS
0.92%
大文字化:
|
ボリューム (24 時間):